Company news

Co-Diagnostics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Co-Diagnostics Announces Third Quarter 2026 Earnings Release Date and Webcast

October 29, 2026

Co-Diagnostics' Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara's SARAGENE® Test

October 29, 2026

Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India

October 27, 2026

Co-Diagnostics' Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum

October 20, 2026

Co-Diagnostics Highlights PCR Platform Capabilities for Potential Plague Detection

October 15, 2026

Co-Diagnostics Announces First Full Vector Smart® Laboratory Installation for Native American Tribe

October 8, 2026

Co-Diagnostics Highlights Vector Smart® Momentum Following New Federal Initiative on Vector-Borne Disease

October 7, 2026

Co-Diagnostics to Showcase Co-Dx PCR Platform* and MTB Test at WHX Labs Johannesburg, Highlight Ebola Assay Development

October 6, 2026

Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week

September 23, 2026

Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation

September 21, 2026

Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026

September 17, 2026

Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola

September 16, 2026

Co-Diagnostics to Hold Press Conference

September 15, 2026

Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India

September 3, 2026

Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base

September 1, 2026

Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event

August 18, 2026

Co-Diagnostics Reports Second Quarter 2026 Financial Results

August 13, 2026

Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast

July 30, 2026

Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies

July 27, 2026

Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform

July 22, 2026

Co Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer

July 16, 2026

Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand

July 7, 2026

Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States

June 25, 2026

Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line

June 18, 2026

Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement

June 11, 2026

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

June 1, 2026

Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

May 25, 2026

Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

May 19, 2026

Co-Diagnostics Reports First Quarter 2026 Financial Results

May 13, 2026

Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City

May 8, 2026

Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast

April 30, 2026

Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.

April 16, 2026

Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany

April 14, 2026

Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah

April 8, 2026

Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City

April 1, 2026

Co-Diagnostics Reports Full Year 2025 Financial Results

March 30, 2026

Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

March 24, 2026

Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia

March 19, 2026

Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast

March 16, 2026

Co-Diagnostics to Present at Medical Korea 2026

March 16, 2026

Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

March 11, 2026

Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

March 10, 2026

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

February 9, 2026

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

February 5, 2026

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

February 4, 2026

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

January 12, 2026

Co-Diagnostics Announces Reverse Stock Split

December 30, 2025

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

December 29, 2025

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India

December 18, 2025

Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation

December 17, 2025

Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks